Description:

MRSN is the ticker symbol for Mateon Therapeutics, Inc., a company listed on the New York Stock Exchange. Mateon Therapeutics focuses on the development of innovative cancer therapies, leveraging advanced technologies in targeted radiotherapies and precision medicine. The company's efforts are geared towards improving treatment outcomes for patients by developing more effective and less toxic options compared to traditional cancer treatments. Through its research and development initiatives, Mateon aims to address unmet medical needs in oncology, positioning itself as a key player in the biotechnology sector.

Data:

Yields: